• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化并发症住院患者的 IGF-I 和 IGFBP-3 血清水平。

IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis.

机构信息

Division of Gastroenterology, Federal University of Santa Catarina, Brazil.

出版信息

Ann Hepatol. 2013 May-Jun;12(3):456-63.

PMID:23619263
Abstract

BACKGROUND

IGF-I and IGFBP-3 are part of IGF system and, due to their predominantly hepatic synthesis, they seem to correlate with hepatic dysfunction intensity.

AIMS

To investigate the significance of IGF-I and IGFBP-3 in patients with decompensated liver disease.

MATERIAL AND METHODS

Cross-sectional study that included cirrhotic patients admitted to hospital due to complications of the disease, in whom IGF-I and IGFBP-3 serum levels were measured by chemiluminescence.

RESULTS

Seventy-four subjects with a mean age of 53.1 ± 11.6 years were included in the study, 73% were males. IGF-I levels were positively correlated with IGFBP-3 and albumin, and negatively correlated with Child-Pugh, MELD, creatinine, INR and aPTT ratio. IGFBP-3 levels were positively correlated with IGF-I and albumin, and negatively correlated with Child-Pugh, MELD, creatinine, INR, total bilirubin and aPTT ratio. Significantly lower scores of IGF-I and IGFBP-3 were observed in patients with higher MELD values and higher Child-Pugh classes (P < 0.05).

CONCLUSIONS

In cirrhotic patients admitted to hospital due to complications of the disease, IGF-I and IGFBP-3 serum levels were associated with variables related to liver dysfunction and to more advanced liver disease. The levels of these markers seem to undergo little influence from other clinical and laboratory variables, therefore mainly reflecting hepatic functional status.

摘要

背景

IGF-I 和 IGFBP-3 是 IGF 系统的一部分,由于它们主要在肝脏中合成,因此它们似乎与肝功能损伤的严重程度相关。

目的

研究 IGF-I 和 IGFBP-3 在失代偿性肝病患者中的意义。

材料和方法

这是一项横断面研究,纳入了因疾病并发症而住院的肝硬化患者,通过化学发光法测量其血清 IGF-I 和 IGFBP-3 水平。

结果

本研究共纳入 74 例患者,平均年龄为 53.1 ± 11.6 岁,男性占 73%。IGF-I 水平与 IGFBP-3 和白蛋白呈正相关,与 Child-Pugh、MELD、肌酐、INR 和 aPTT 比值呈负相关。IGFBP-3 水平与 IGF-I 和白蛋白呈正相关,与 Child-Pugh、MELD、肌酐、INR、总胆红素和 aPTT 比值呈负相关。MELD 值较高和 Child-Pugh 分级较高的患者 IGF-I 和 IGFBP-3 的评分明显较低(P < 0.05)。

结论

在因疾病并发症而住院的肝硬化患者中,血清 IGF-I 和 IGFBP-3 水平与肝功能损伤的相关变量以及更严重的肝病相关。这些标志物的水平似乎很少受到其他临床和实验室变量的影响,因此主要反映了肝脏的功能状态。

相似文献

1
IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis.肝硬化并发症住院患者的 IGF-I 和 IGFBP-3 血清水平。
Ann Hepatol. 2013 May-Jun;12(3):456-63.
2
Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis.肝硬化患者血清胰岛素样生长因子-1(IGF-1)和胰岛素样生长因子结合蛋白-3(IGFBP-3)水平
Turk J Gastroenterol. 2007 Dec;18(4):245-9.
3
Serum insulinlike growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplant.等待肝移植的肝硬化患儿的血清胰岛素样生长因子-1及其结合蛋白-3水平
Exp Clin Transplant. 2012 Jun;10(3):252-7. doi: 10.6002/ect.2011.0095.
4
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.血清胰岛素样生长因子-I、胰岛素样生长因子-II及胰岛素样生长因子结合蛋白-3在肝硬化中的临床意义
World J Gastroenterol. 2004 Sep 15;10(18):2740-3. doi: 10.3748/wjg.v10.i18.2740.
5
Insulin-like growth factor I correlates with MELD and returns to normal level after liver transplantation.胰岛素样生长因子I与终末期肝病模型(MELD)评分相关,且在肝移植后恢复至正常水平。
Ann Transplant. 2013 Feb 12;18:57-62. doi: 10.12659/AOT.883819.
6
Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.1型和2型糖尿病患者血清胰岛素样生长因子系统成分水平及其与骨代谢的关系。
J Endocrinol. 1998 Nov;159(2):297-306. doi: 10.1677/joe.0.1590297.
7
Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.肝细胞癌患者中胰岛素样生长因子-I(IGF-I)与胰岛素样生长因子结合蛋白-3(IGFBP-3)的比值升高。
Clin Endocrinol (Oxf). 2003 Dec;59(6):699-706. doi: 10.1046/j.1365-2265.2003.01909.x.
8
The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease.血清缺血修饰白蛋白评估慢性肝病患者肝功能的价值。
Clin Chem Lab Med. 2011 Nov;49(11):1817-21. doi: 10.1515/CCLM.2011.675. Epub 2011 Aug 19.
9
Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis.生长激素刺激的胰岛素样生长因子(IGF)I及肝硬化时的IGF结合蛋白-3
J Hepatol. 1997 Nov;27(5):796-802. doi: 10.1016/s0168-8278(97)80315-7.
10
The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis.胰岛素样生长因子结合蛋白3三元复合物在肝硬化中减少。
Liver. 2001 Oct;21(5):350-6. doi: 10.1034/j.1600-0676.2001.210508.x.

引用本文的文献

1
Insulin-like Growth Factor-1 Levels Reflect Muscle and Bone Health and Determine Complications and Mortality in Decompensated Cirrhosis.胰岛素样生长因子-1水平反映失代偿期肝硬化患者的肌肉和骨骼健康状况,并决定其并发症和死亡率。
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102402. doi: 10.1016/j.jceh.2024.102402. Epub 2024 Aug 12.
2
Emerging role of liver-bone axis in osteoporosis.肝-骨轴在骨质疏松症中的新作用
J Orthop Translat. 2024 Sep 4;48:217-231. doi: 10.1016/j.jot.2024.07.008. eCollection 2024 Sep.
3
Clinical Indicators of Bone Deterioration in Alcoholic Liver Cirrhosis and Chronic Alcohol Abuse: Looking beyond Bone Fracture Occurrence.
酒精性肝硬化和慢性酒精滥用中骨质恶化的临床指标:超越骨折发生率的研究
Diagnostics (Basel). 2024 Feb 28;14(5):510. doi: 10.3390/diagnostics14050510.
4
Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis.胰岛素样生长因子1可预测代偿期肝硬化患者的失代偿及长期预后。
Front Med (Lausanne). 2023 Jul 24;10:1233928. doi: 10.3389/fmed.2023.1233928. eCollection 2023.
5
Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice.人羊膜间充质干细胞衍生的 IGFBP-3、DKK-3 和 DKK-1 通过阻断 Wnt/β-连环蛋白信号通路抑制肝星状细胞活化,减轻小鼠肝纤维化。
Stem Cell Res Ther. 2022 Jun 3;13(1):224. doi: 10.1186/s13287-022-02906-z.
6
Research Progress and Treatment Status of Liver Cirrhosis with Hypoproteinemia.肝硬化合并低蛋白血症的研究进展与治疗现状
Evid Based Complement Alternat Med. 2022 Feb 24;2022:2245491. doi: 10.1155/2022/2245491. eCollection 2022.
7
Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study.血清胰岛素样生长因子-1在肝细胞癌患者中的预后意义:一项验证研究
J Hepatocell Carcinoma. 2020 Sep 16;7:143-153. doi: 10.2147/JHC.S258930. eCollection 2020.
8
Insulin-Like Growth Factor (IGF) System in Liver Diseases.肝脏疾病中的胰岛素样生长因子(IGF)系统。
Int J Mol Sci. 2018 Apr 27;19(5):1308. doi: 10.3390/ijms19051308.
9
Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma.I 型胰岛素样生长因子作为肝癌肝储备评估工具。
J Hepatocell Carcinoma. 2015 Sep 18;2:131-42. doi: 10.2147/JHC.S81309. eCollection 2015.
10
Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis.循环胰岛素样生长因子结合蛋白3作为肝硬化的预后生物标志物
World J Hepatol. 2016 Jun 18;8(17):739-48. doi: 10.4254/wjh.v8.i17.739.